Egrifta, With Help From Patient Testimonies, Gets Advisory Committee Recommendation
This article was originally published in The Pink Sheet Daily
Executive Summary
Unanimous vote for Theratechnologies' HIV lipodystrophy drug by Endocrinologic and Metabolic Drugs Advisory Committee acknowledges need for post-marketing safety work.